| | | | |

Mesothelioma Patients May Benefit From Kindness, Study Reveals

A study of more than 400 patients and their families shows that people coping with cancers such as malignant mesothelioma do better when their medical caregivers show them kindness.

The study was originally published in the Journal of Oncology Practice and identifies six specific types of kindness that can help to ease the pain and challenges of mesothelioma treatment.

High Tech Must Be Balanced by “High Touch”

In the introduction to the report, Dr. Leonard Berry, a University Distinguished Professor of Marketing at Texas A&M University, says high tech therapies for mesothelioma and other cancers  should be balanced by “high touch” from caregivers.

“Simple kindness can help to diffuse negative emotions that are associated with cancer diagnosis and treatment—and may even help to improve patients’ outcomes,” he writes.

Receiving a diagnosis of mesothelioma, an aggressive cancer that is highly resistant to standard therapies, can be especially devastating to patients and families, most of whom had no idea they were ill until the cancer was in an advanced stage.

Previous studies have shown that malignant mesothelioma in particular can bring up feelings of guilt and shame because it is almost always caused by avoidable asbestos exposure. Even when patients did not know they were being exposed or were not made aware of the risks, it is common for them to imagine that they “might have done something differently” to avoid their mesothelioma.

 

Six Types of Kindness for People in Mesothelioma Treatment

Malignant mesothelioma tends to grow and spread quickly after diagnosis, making compassionate care crucial from the very first appointment.

In the study “Role of Kindness in Cancer Care”, Dr. Berry and his colleagues say kindness in cancer care is about more than a smile or a touch. Even the amount of time it takes doctors to get back to cancer patients matters.

Berry and his colleagues propose six ways in which caregivers may be able to help ease of the pain for mesothelioma patients and others on their cancer journeys.

  • Deep Listening – When mesothelioma patients feel heard, they feel understood. In addition, caregivers can offer better care when they truly understand the patient’s needs and concerns.
  • EmpathyMesothelioma doctors and nurses should attempt to imagine themselves in the patient’s situation to more fully appreciate and alleviate suffering.
  • Acts of Kindness – These can include simple helpful acts, such as offering a foot massage during mesothelioma chemotherapy or taking the time to teach a mesothelioma patient or family members how to properly use their chest drain.
  • Timely care – For patients with aggressive cancers like malignant mesothelioma, waiting for test results or for treatment can be excruciating. Dr. Berry urges providers to offer care in a timely manner to reduce stress and anxiety.
  • Gentle Honesty – The Texas A&M study found that patients with mesothelioma and other cancers prefer their doctors to be honest about their prognosis, but to temper that honestly with hope and gentleness.
  • Support for family caregivers – Mesothelioma patients often depend heavily on their family members for care, making the health and mental well-being of those family members a vital part of their care and prognosis.

In conclusion, Dr. Berry offers these words of advice for mesothelioma caregivers and others who care for people with cancer:

“These mutually reinforcing manifestations of kindness—exhibited by self-aware clinicians who understand that how care is delivered matters—constitute a powerful and practical way to temper the emotional turmoil of cancer for patients, their families, and clinicians themselves,” he writes.

Sources:

Berry, Leonard, et al, “Role of Kindness in Cancer Care”, November 2017, Journal of Oncology Practice

Berry, Leonard, “How kindness can make a difference in cancer care”, February 1, 2018, The Conversation

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…